1 year return (CAGR)
-96.95%
Kala Pharmaceuticals Inc Exchange (NASDAQ, USD)
KALA
0.60
+0.04 (+6.96%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-61.66%
5 year return (CAGR)
-24.11%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
11.58M
Price/Sales
-
Ent value
12.89M
Price/Book
1.28
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
16.32%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.57 |
| Daily high | 0.61 |
| Daily low | 0.55 |
| Daily Volume | 134K |
| All-time high | 42.09 |
| 1y analyst estimate | 1.50 |
| Beta | -2.28 |
| EPS (TTM) | -135.92 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KALA | S&P500 | |
| Current price drop from All-time high | -98.58% | -0.58% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 8 May 2026 | 9 Mar 2009 |
| Avg drop from high | -74.30% | -10.68% |
| Avg time to new high | 121 days | 12 days |
| Max time to new high | 1332 days | 1805 days |
News
